4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000112
Chief Operating Officer sold 2,241 shares at $32.06 ($71,846)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gloria Melanie Chief Operating Officer | 2026-10-07 | Sale | −2,241 | $32.06 | $71,846 | 217,060 | D |
| Open-market sales · 2,241 sh · avg $32.06 · $71,846 | |||||||
Loading xslF345X06/wk-form4_1791579845.xml…